These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9546133

  • 1. [A case of poorly differentiated adenocarcinoma of prostate with neuroendocrine differentiation].
    Miyoshi Y, Inoue Y, Matsuzaki J, Fukuda M, Satomi Y, Akahane H, Saito S.
    Hinyokika Kiyo; 1998 Feb; 44(2):113-6. PubMed ID: 9546133
    [Abstract] [Full Text] [Related]

  • 2. [A case of prostate cancer treated with combined androgen-blockade].
    Kurita M, Kato Y, Tamura Y, Suzuki K, Yamanaka H.
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):307-10. PubMed ID: 10700907
    [Abstract] [Full Text] [Related]

  • 3. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].
    Matsumoto Y, Mibu H, Kagebayashi Y.
    Hinyokika Kiyo; 2004 Nov; 50(11):813-5. PubMed ID: 15628545
    [Abstract] [Full Text] [Related]

  • 4. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report].
    Segawa N, Inamoto T, Ibuki N, Mizutani Y, Azuma H, Tsuji M, Katsuoka Y.
    Hinyokika Kiyo; 2010 Jan; 56(1):49-54. PubMed ID: 20104011
    [Abstract] [Full Text] [Related]

  • 5. [Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report].
    Kitamoto K, Hayashi T, Tamada S, Ezaki K, Kawashima H, Sugimura K, Nakatani T.
    Hinyokika Kiyo; 2005 Jan; 51(1):33-5. PubMed ID: 15732339
    [Abstract] [Full Text] [Related]

  • 6. [Giant prostate carcinoma treated effectively with endocrine therapy: case report].
    Masue N, Hasegawa Y.
    Hinyokika Kiyo; 2007 Feb; 53(2):133-5. PubMed ID: 17352166
    [Abstract] [Full Text] [Related]

  • 7. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases].
    Sakuma T, Yoshida T, Ohashi H, Nishimura K, Kawano K.
    Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184
    [Abstract] [Full Text] [Related]

  • 8. The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.
    Mosca A, Berruti A, Russo L, Torta M, Dogliotti L.
    J Endocrinol Invest; 2005 Jul; 28(11 Suppl International):141-5. PubMed ID: 16625864
    [Abstract] [Full Text] [Related]

  • 9. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ.
    Cancer Res; 2001 Mar 01; 61(5):2239-49. PubMed ID: 11280793
    [Abstract] [Full Text] [Related]

  • 10. [A case of completely responding stage D2 prostatic cancer with no evidence of disease 14 years after diagnosis].
    Tsuzuki M, Kawakami S, Yonese J, Ueda T, Kageyama S, Yamauchi T, Kawai T.
    Hinyokika Kiyo; 1994 Sep 01; 40(9):837-40. PubMed ID: 7801848
    [Abstract] [Full Text] [Related]

  • 11. New perspective in the management of neuroendocrine differentiation in prostate adenocarcinoma.
    Sciarra A, Cardi A, Dattilo C, Mariotti G, Di Monaco F, Di Silverio F.
    Int J Clin Pract; 2006 Apr 01; 60(4):462-70. PubMed ID: 16620361
    [Abstract] [Full Text] [Related]

  • 12. [Neuroendocrine differentiation and metastasized to brain stem, intraorbit and base of tongue in prostate cancer during hormonal treatment: a case report].
    Sugi M, Yanishi M, Shimada O, Kawakita S, Murota T, Shikata N.
    Hinyokika Kiyo; 2008 May 01; 54(5):373-6. PubMed ID: 18546865
    [Abstract] [Full Text] [Related]

  • 13. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
    Rimoldi DA, Antonio Costa J, Roveto S, Rivero O.
    Medicina (B Aires); 2001 May 01; 61(3):322-4. PubMed ID: 11474882
    [Abstract] [Full Text] [Related]

  • 14. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
    Yamamoto A, Sumiyoshi Y, Miyake N, Yokozeki H, Kanayama H, Kagawa S.
    Hinyokika Kiyo; 1998 Aug 01; 44(8):557-63. PubMed ID: 9783191
    [Abstract] [Full Text] [Related]

  • 15. [Small cell carcinoma of the prostate: a case report].
    Yamamoto N, Kinoshita H, Inoue T, Kawakita S, Oguchi N, Muguruma K, Kawa G, Sakaguchi Y, Adachi Y, Sakaida N, Uemura Y, Matsuda T.
    Hinyokika Kiyo; 2007 Sep 01; 53(9):665-9. PubMed ID: 17933147
    [Abstract] [Full Text] [Related]

  • 16. Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
    Jongsma J, Oomen MH, Noordzij MA, Van Weerden WM, Martens GJ, van der Kwast TH, Schröder FH, van Steenbrugge GJ.
    Cancer Res; 2000 Feb 01; 60(3):741-8. PubMed ID: 10676662
    [Abstract] [Full Text] [Related]

  • 17. [A case of prostate cancer with cyst formation].
    Ishida K, Kubota Y, Takada T, Yamada T, Nakano M, Takahashi Y, Ishihara S, Deguchi T.
    Hinyokika Kiyo; 2003 Apr 01; 49(4):235-7. PubMed ID: 12784721
    [Abstract] [Full Text] [Related]

  • 18. Neuroendocrine differentiation of localized prostate cancer during endocrine therapy.
    Nemoto K, Tomita Y.
    Scand J Urol Nephrol; 2007 Apr 01; 41(6):558-60. PubMed ID: 17853028
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive expression analysis of L-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors.
    Wafa LA, Palmer J, Fazli L, Hurtado-Coll A, Bell RH, Nelson CC, Gleave ME, Cox ME, Rennie PS.
    Hum Pathol; 2007 Jan 01; 38(1):161-70. PubMed ID: 16997353
    [Abstract] [Full Text] [Related]

  • 20. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status.
    Bonkhoff H.
    Prostate Suppl; 1998 Jan 01; 8():18-22. PubMed ID: 9690659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.